INTERNATIONAL PATENT: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM FILES APPLICATION FOR "HUMANIZED MONOCLONAL ANTIBODIES AGAINST MHC-CLASS II PROTEINS FOR CANCER IMMUNOTHERAPY"

GENEVA, April 14 -- THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (210 West 7th StreetAustin, Texas 78701) filed a patent application (PCT/US2025/048756) for "HUMANIZED MONOCLONAL ANTIBODIES AGAINST MHC-CLASS II PROTEINS FOR CANCER IMMUNOTHERAPY" on Sep 30, 2025. With publication no. WO/2026/075997, the details related to the patent application was published on Apr 09, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BEUTLER, Bruce A. (5323 Harry Hines BoulevardDallas, Texas 75390), SHI, Hexin (5323 Harry Hines BoulevardDallas, Texas 75390)

Abstract: Aspects of the present disclosur...